|
Volumn 353, Issue 9164, 1999, Pages 1620-1621
|
Thromboprophylaxis for atrial fibrillation [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
WARFARIN;
BLEEDING;
CLINICAL TRIAL;
DRUG CONTRAINDICATION;
DRUG RESEARCH;
HEART ATRIUM FIBRILLATION;
HUMAN;
LETTER;
PATIENT MONITORING;
PATIENT SELECTION;
PRIORITY JOURNAL;
STROKE;
THROMBOSIS;
AGED;
CHEMICALLY INDUCED DISORDER;
CONTROLLED CLINICAL TRIAL;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
HEMORRHAGE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
WARFARIN;
|
EID: 0033535632
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)75742-1 Document Type: Letter |
Times cited : (12)
|
References (5)
|